![Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/f516168b-ca27-473e-b972-7e038d69ea88/gr1.gif)
Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine
![Azithromycin induces anti-viral responses in bronchial epithelial cells | European Respiratory Society Azithromycin induces anti-viral responses in bronchial epithelial cells | European Respiratory Society](https://erj.ersjournals.com/content/erj/36/3/646/F2.large.jpg)
Azithromycin induces anti-viral responses in bronchial epithelial cells | European Respiratory Society
![Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet](https://www.thelancet.com/cms/asset/2ffb2e5b-9e76-4765-a065-5fab6b80633d/gr1.jpg)
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet
![Efficacy of azithromycin in severe asthma from the AMAZES randomised trial | European Respiratory Society Efficacy of azithromycin in severe asthma from the AMAZES randomised trial | European Respiratory Society](https://openres.ersjournals.com/content/erjor/5/4/00056-2019/F1.large.jpg)
Efficacy of azithromycin in severe asthma from the AMAZES randomised trial | European Respiratory Society
![Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea.,The Lancet - X-MOL Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea.,The Lancet - X-MOL](https://xpic.x-mol.com/20180312%2F10.1016_S2214-109X%2818%2930023-8.jpg)
Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea.,The Lancet - X-MOL
![PDF] Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. | Semantic Scholar PDF] Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/562ad2c017af7c2f6fde4945521ff21cc2c5e818/2-Table1-1.png)
PDF] Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. | Semantic Scholar
![Pharmacokinetics and Pharmacodynamics of Intravenous and Oral Azithromycin: Enhanced Tissue Activity and Minimal Drug Interactions | Semantic Scholar Pharmacokinetics and Pharmacodynamics of Intravenous and Oral Azithromycin: Enhanced Tissue Activity and Minimal Drug Interactions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ea131fb07093200050732b8ec43240efe19ee6c5/3-Table2-1.png)
Pharmacokinetics and Pharmacodynamics of Intravenous and Oral Azithromycin: Enhanced Tissue Activity and Minimal Drug Interactions | Semantic Scholar
![COVID-19: Can early home treatment with Azithromycin alone or with Zinc help prevent hospitalisation, death, and long-COVID-19? A review | medRxiv COVID-19: Can early home treatment with Azithromycin alone or with Zinc help prevent hospitalisation, death, and long-COVID-19? A review | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/01/04/2020.12.29.20248975/F2.large.jpg)
COVID-19: Can early home treatment with Azithromycin alone or with Zinc help prevent hospitalisation, death, and long-COVID-19? A review | medRxiv
Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs) | Aging
![Effects of Azithromycin in Combination with Vancomycin, Daptomycin, Fosfomycin, Tigecycline, and Ceftriaxone on Staphylococcus epidermidis Biofilms | Antimicrobial Agents and Chemotherapy Effects of Azithromycin in Combination with Vancomycin, Daptomycin, Fosfomycin, Tigecycline, and Ceftriaxone on Staphylococcus epidermidis Biofilms | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.01628-08/asset/2e3e42e0-c42c-4a00-ac62-f15a4d34b333/assets/graphic/zac0080982780001.jpeg)
Effects of Azithromycin in Combination with Vancomycin, Daptomycin, Fosfomycin, Tigecycline, and Ceftriaxone on Staphylococcus epidermidis Biofilms | Antimicrobial Agents and Chemotherapy
![Antibiotic Steward Bassam Ghanem🆔🌟 on Twitter: "⛔In a Sarcastic way ⛔ This study doesn't prove anything Hydroxychloroquine designed to be effective in #COVID19 patients only when you add Azithromycin and Zinc together. Antibiotic Steward Bassam Ghanem🆔🌟 on Twitter: "⛔In a Sarcastic way ⛔ This study doesn't prove anything Hydroxychloroquine designed to be effective in #COVID19 patients only when you add Azithromycin and Zinc together.](https://pbs.twimg.com/media/EhJWuQ-WAAAYgdq.jpg)